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It  has  been  shown that  the  limited gonadotropic effect of prolan 
can be greatly enhanced by the simultaneous injection of a  synergic 
principle from the hypophysis (1, 2).  This suggested that the method 
could be  used  to  demonstrate  the presence of prolan or prolan-like 
substances  occurring  in  blood  or  urines  in  conditions  other  than 
pregnancy. 
The occurrence of a gonad-stimulating substance in the urine of men 
is  manifested  in  certain  pathological  conditions  (castration,  genital 
carcinoma) (3, 4), but no evidence for the presence of such a substance 
in normal male urine has ever been obtained.  In the course of this 
study,  various  methods  for  the  concentration  of  prolan  have  been 
applied to male urinO and in the best concentrates (alcohol-ammonia 
extracts) it has been possible to demonstrate the presence of a prolan- 
like substance by  administering it  alone.  Further,  when these con- 
centrates  were  strengthened  by  the  addition  of  the  synergic  factor 
from the hypophysis, a  significant augmentation of the infantile rat 
ovaries was elicited.  This was the case with both the crude alcohol 
precipitate and  the more concentrated extract  (Table  I). 
* Aided by grants from the Rockefeller Foundation and from the Committee 
for Research in Problems of  Sex of the  National  Research  Council.  We desire 
here also to express our thanks to the I. G. of Elberfeld, Germany, who, through 
Drs. H. H6rlein, W. Schulemann and F. Laqueur, placed generous amounts of pro- 
lan at our disposal, and finally, to Eli Lilly and Company of Indianapolis, without 
whose assistance in securing hypophyseal products this research would have been 
impossible. 
i We are grateful to Dr. J. A. Morrell of E.  R.  Squibb and Sons for generous 
supplies of a concentrate from urine of normal men. 
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It is a matter of no little concern to the physiologist that prolan has 
been found almost solely in the serum and urine of primates.  With 
the sensitive synergism test at hand, it seemed important to inquire 
if small amounts of prolan-like substances could not be detected in 
the sera and urine of non-primates.  Evidence to the effect that gon- 
adotropic substances do in fact occur in mammals other than primates 
TABLE  I 
Response of the Immature Female Rat to a Combination of the Hypophyseal Synergic 
Principle with Prolan-Like Substances from Human Sources 
Prolan-like substance 
Source 
Pregnancy serum,  acetone-ammonia 
extract R2438 
Placenta, alcohol precipitate of aque- 
ous acetone extract R2384 
Normal male urine (age 20--40 yrs.) 
Crude alcohol precipitate R2666 
Reprecipitated from alcohol R2346 
Alcohol-ammonia extract R2662 
Alcohol-ammonia extract R2442 
rag.  rag. 
54.4  36 
27.3  26 
54.4  20 
27.3  17 
272  12 
163  15 
272  16 
215  28 
Description of 
ovaries 
2-6 corpora 
2-6  " 
Large follicles 
tt  ~ 
Infantile 
~6 
3-8 corpora 
3--4  " 
q 
rag. 
2.7 
2.7 
2.7 
2.7 
2.7 
2.7 
Combina- 
tion* 
(in vitroJ 
..-. 
per 
rag.  rag.  cent 
25  82  O0 
57  72 
20  94  827 
38  90 
32  66  106 
17  54  200 
32  81  15fi 
25  53  51 
* The given weights of the two components were mixed in vitro  and injected 
subcutaneously, daily, on 3 successive days with autopsy after 96 hours (1,  2). 
Three rats were used in each group. 
has accumulated from parabiotic studies (Matsuyama  (5)).  Martins 
(6) and Emery (7) found by direct injection that the blood of the cas- 
trate  male  and female  rat  contains  a  gonadotropic  substance.  The 
sera of normal males and pregnant or non-pregnant females gave only 
a negative reaction as did the urines of all animals studied.  Jeffcoate 
(8)  found that gonadectomized  rabbits  excrete  a  gonad-stimulating 
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Rats  afforded  the  most  convenient  material for the  present  study 
and  injection of sera or urinary  concentrates from normal males and 
females,  castrate  and  cryptorchid  males  and  pregnant  females  all 
gave  a  negative  reaction.  By means  of the  synergism phenomenon, 
TABLE  II 
Demonstration  of a  Prolan-Like  Substance  in  the  Urine  and  Blood  Serum  of Rats 
Injected in male rats  Prolan-like substance injected in female rats (3 days)  (10 days)t 
Source 
Weight 
Dose  of 
ovaries 
Combination  "~ 
with synergic  .- 
factor*  ~  ~o 
C,n T,  itro)  Dose  "~ ~  '~ 
~'~  ~  Weight  Activa-  .. 
of 
ovaries  tion 
rag.  per cent  co.  rag.  rag. 
77  320  10  10  540 
46  150  10  10  509 
65  260  10  8  470 
58  220  10  10  447 
41  105  10  9  520 
--  (9) (446) 
cc.  rag. 
.'astrate rat blood serum~ R3555  3  18 
~'ryptorchid rat blood semm:~ R3561  3  12 
;Iormal female rat blood serum R3557  3  14 
'regnant rat blood serum R3558  3  14 
(ormal male rat blood serum R3559  3  20 
Controls) 
rag.  rag. 
~'astrate  rat  urine,  alcohol  precipitate  136  12  62  244  270  7  376 
R3189 
~'ryptorchid rat urine, alcohol precipitate  88i  10  61  238  270  8  232 
R3191 
'regnant  rat  urine,  alcohol  precipitate  161  15  37  105 
R3040 
~ormal female rat urine, alcohol precipi-  137  18  48  150 
tate R3467 
Controls)  --  (10)  (392) 
* Synergic factor: dose, 1.36 rag.; weight of ovaries, 18 mg. 
t  As routine, six male rats, 21-25 days of age were used in each group. 
Male rats were rendered cryptorchid or castrate 3 weeks previous to the collec- 
tion of their urines and sera. 
however,  it was possible to demonstrate  the presence of a  prolan-like 
substance  in each of the above cases.  These results are summarized 
in Table II. 
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of  rats  led  to  a  similar  investigation  of  other  animal  forms.  The 
findings  in  the  rat  were largely  confirmed.  Serum of pregnant  and 
non-pregnant  cow,  ~ pregnant  and  non-pregnant  pig  and  urines  of 
pregnant  and non-pregnant  guinea  pig  and  pregnant  dog  were  all 
negative when injected alone and all gave activation when combined 
with  the  synergic factor.  The  urine  of pregnant  and  non-pregnant 
rabbits, 3 however, showed but slight activation when tested similarly 
and the urine of pregnant mares, none at all.  These results are sum- 
marized in Table III. 
Since  the  activation  phenomenon  has been observed in  many  in- 
stances  regardless  of whether  or not the  prolan-like  substances was 
positive by itself, it seemed worthwhile to give subminimal  doses of 
prolan from pregnancy urine with the synergic factor.  In Table IV 
is shown the effect of combining varying doses of prolan with a constant 
amount of the hypophyseal component.  It was rather  surprising  to 
find that pregnancy prolan was potent in doses lower than those which 
showed the  activation phenomenon.  It is,  therefore,  apparent  that 
the prolan-like material present in most non-pregnancy urine is differ- 
ent from that in pregnancy. 
Because of the theoretical interest attached to the possible origin of 
prolan and prolan-like bodies from the hypophysis it seemed important 
to determine whether or not gonadotropic  substances when  actually 
injected into rats would reappear in their urine.  Ehrhardt has shown 
(11) that the urine of a non-pregnant woman contained prolan shortly 
after she had received a  blood transfusion from a pregnant  woman. 
In this study prolan and pregnant mare's serum were injected into 
separate  groups  of  rats  and  their  urine  was collected,  concentrated 
and assayed.  Rats injected with prolan secreted at least a portion of 
it in their urine (quantitative recovery was not attempted).  Both the 
native urine and the concentrates gave positive reactions.  Thus 6 cc. 
of the  sevenfold concentrated  urine gave 62 mg.  ovaries.  However, 
Leonard (9) has presented data that indicate the presence of prolan-like sub- 
stances in  the urine of pregnant  and non-pregnant  cows.  Combination of the 
urinary  product  with  the follicle stimulator  (10) (which contains  the synergic 
principle) gave increased ovary weights. 
We desire to thank Drs. Wade Brown and Louise Pearce for placing rabbits of 
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urine from rats receiving pregnant mare's serum could not be differen- 
tiated from urine of uninjected controls.  This is in agreement with 
the fact that no gonadotropic hormone is found in the urine of the 
pregnant mare. 
Realizing that the physiological  mechanism of the rat differs from 
that of primates in the handling of gonadotropic substances, we in- 
jected rhesus monkeys intravenously with pregnant mare's serum and 
hypophyseal gonad-stimulating substance (pig flavianate preparation). 
The  urines  were  collected,  concentrated and  assayed in  immature 
TABLE  IV 
Effect of Combination of Varying Doses of Prolan with a Constant Amount  of the 
Synergic Principle from the Itypophysis 
Prolan (R3082)  Synergic principle (pig)  Combination (in vitro) 
Dose  Weight of  Description  Weight of  Weight of  Activation 
ovaries  of ovaries  Dose  ovaries  ovaries 
mg. 
13.6 
6.8 
2.7 
1.36 
0.54 
0.27 
mg. 
43 
44 
30 
32 
29 
15 
Large  fol- 
licles 
and cor- 
pora 
Few  cor- 
pora 
Infantile 
mg.  mg. 
21 
I(Small 
1.36  ~and  me- 
|dium folli- 
Leles  only) 
mg. 
155 
128 
75 
60 
37 
26 
~er 6e~ 
237 
172 
127 
71 
15 
23 
female rats.  A gonadotropic hormone was abundantly demonstrated 
in the urine of the monkeys injected with the hypophyseal hormone. 
An ovary weight of 62 rag. was elicited by the injection of a total dose 
of 69 nag. of the urinary concentrate.  Combination with the synergic 
substance did not further increase the ovary weights.  The urinary 
product from the monkeys injected with pregnant mare's serum con- 
tained no gonadotropic substance.  The results were, therefore, com- 
parable to those in the rat.  Further, the urine did not show the acti- 
vation phenomenon on combination with the synergic principle.  The 
urine from normal controls did not cause ovarian development when 
injected alone or in combination with the synergic factor. H. M. EVANS,  M. E.  SIMPSON,  AND  PAUL  R. AUSTIN  567 
Since the synergic principle from the  hypophysis has such a  pro- 
nounced effect on the ovaries when combined with prolan it was of 
interest to  see if there was a  similar effect on the seminal vesicles. 
TABLE  V 
Response of the Immature Male Rat to a Combination of the Synergic Principle from 
the Itypophysis with Prolan from Pregnancy Urine 
Materialinjected 
Prolan 
Synergie principle 
Prolan plus synergic 
principle 
(Controls) 
Injected 3 days, 
sacrificed  5th day, R1989 
Weight i Weight  of  Dose  seminal  of 
vesicles  testes 
rag.  mg.  rag. 
27.3  33  471 
27.3  7  267 
49  535 
(8)  (3081 
Injected 11 days, 
sacrificed 12th day, R2276 
Dose 
rag. 
110 
11 
Injected 19 days, 
mcrificed 20th day, R2658 
Welgat 
seminal  of  Dose 
vesicles  testes 
mg.  rag.  rag. 
85  610  180 
7  395  18 
119  749 
(6)  (498) 
Weight I  of  [ Weight 
seminal  I  of  vesicles testes 
mg.  mg, 
125  900 
26  805 
372  1362 
(13)  (483) 
TABLE  VI 
Response of the Immature Male Rat to a Combination of the Synergic Principle from 
the Hypophysis with Prolan-Like  Substances from Human Sources 
 rolani' esohstaoce  S °e  Corin  io I  l---- 
rag.  mg.  rag. 
ine  2761110185  6101  "g"  I  "g'  I  "g"  /  "g"  I  "g"  /  "g"  I  "g"  11  ]  7139711191749  I  6  /492 
rur~  3066 /  90  /  54  689  /  4"5/  15  /  730[  41  / 785  ]  9  [ 444 
male  urine]660]  6  3651  11  [  7  ]397  /  716131  6  ]492 
Source 
Pregnancy urine R2276 
Pregnancy serum R3066 
Normal 
R2277 
This was found to be the case: The synergic principle itself had little 
or no effect, but in  combination with pregnancy prolan it  caused a 
definite increase in the development of the seminal vesicles (Table V). 
These results also indicate that the  10 day test is adequate for the 
attainment of significant values. 568  PROLAN AND  PROLAN-LIKE SUBSTANCES 
The action of prolan-like substances from various sources on the 
testes and seminal vesicles is shown in Table VI and also  in Tables 
II  and  III.  It  is  perhaps  significant  that  all  of  the  non-primate 
sources, shown to contain a prolan-like substance as evidenced by the 
activation phenomenon with immature females, were uniform in their 
lack of effect on the testes and seminal vesicles.  Normal male urine 
conformed to the above classification. 
SUMMARY 
The synergism phenomenon has made possible  the recognition of 
substances, which we have called "prolan-like,"  in a wide variety of 
conditions.  Indeed, it has been possible to demonstrate a prolan-like 
material in the urine of normal men. 
The method has shown a wide distribution of prolan-like substances 
in sera and urines of non-primates without demonstrating, however, 
significant difference in the reactions secured from pregnant as con- 
trasted with non-pregnant states, or in males as contrasted with females. 
The  synergism phenomenon with  pregnancy prolan  can  also  be 
shown in  the increased development of the  seminal vesicles  of im- 
mature male rats.  However, such males cannot be advantageously 
employed in  the  detection  of  prolan-like  gonadotropic  substances 
occurring in the blood and urine in conditions other than pregnancy, 
for the prolan-like substances usually do not effect appreciable develop- 
ment of the seminal vesicles. 
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